However, gene expression of HAVCR2 and TIM-3 promoter activity was rapidly and significantly reduced in mouse and rat primary microglia exposed to conditioned media from mouse, rat, and human glioma cell lines, and in glioma bearing mice in vivo. The gene discussed is HAVCR2; the disease is central nervous system cancer.